where U represents the formula (A) or (B) where V represents hydrogen or halogen atom, (C1-C3)-alkyl group or one either two (C1-C3)-alkoxy-groups; each of W and X represents two oxygen atoms either oxygen atom and group CH2 or group CH2 and oxygen atom, either oxygen atom and group CO; n = 0 or 1; R represents propyl group when U means the formula (A) either hydrogen atom or (C1-C3)-alkyl when U means the formula (B); Y represents one or more atoms or group including hydrogen, halogen atom and so on; Z represents hydrogen, oxygen atom. Invention relates also to drug containing compound of the formula (I) showing affinity to dopaminergic receptors of type D2 and D3 and serotoninergic receptors of type 5-HT1A and 5-HT2 and to pharmaceutical composition showing affinity to dopaminergic receptors of type D2 and D3 and serotoninergic receptors of type 5-HT1A and 5-HT2 containing compound of the formula (I) and excipient. Invention provides synthesis of novel derivatives of 8-azabicyclo[3.2.1]octane- -3-methanamine. EFFECT: valuable medicinal and pharmacological properties of compounds. 6 cl, 3 tbl"/> DERIVATIVES OF 8-AZABICYCLO3,2,1OCTANE-3-METHAN- AMINE AS LIGANDS OF DOPAMINE RECEPTORS D<Sub>2</Sub> AND D<Sub>3</Sub> AND SEROTONIN RECEPTORS 5-HT<Sub>1A</Sub> AND 5-HT<Sub>2</Sub> AND DRUG AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
首页> 外国专利> DERIVATIVES OF 8-AZABICYCLO3,2,1OCTANE-3-METHAN- AMINE AS LIGANDS OF DOPAMINE RECEPTORS D2 AND D3 AND SEROTONIN RECEPTORS 5-HT1A AND 5-HT2 AND DRUG AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF

DERIVATIVES OF 8-AZABICYCLO3,2,1OCTANE-3-METHAN- AMINE AS LIGANDS OF DOPAMINE RECEPTORS D2 AND D3 AND SEROTONIN RECEPTORS 5-HT1A AND 5-HT2 AND DRUG AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF

机译:多巴胺受体D 2 和D 3 和血清素受体5-HT 1A 和5-HT 2 及其所含药物和药物成分

摘要

FIELD: organic chemistry, medicine, pharmacology. SUBSTANCE: invention relates to novel derivatives of 8-azabicyclo[3.2.1]octane-3- -methanamine as pure geometrical -isomers of the general formula (I) where U represents the formula (A) or (B) where V represents hydrogen or halogen atom, (C1-C3)-alkyl group or one either two (C1-C3)-alkoxy-groups; each of W and X represents two oxygen atoms either oxygen atom and group CH2 or group CH2 and oxygen atom, either oxygen atom and group CO; n = 0 or 1; R represents propyl group when U means the formula (A) either hydrogen atom or (C1-C3)-alkyl when U means the formula (B); Y represents one or more atoms or group including hydrogen, halogen atom and so on; Z represents hydrogen, oxygen atom. Invention relates also to drug containing compound of the formula (I) showing affinity to dopaminergic receptors of type D2 and D3 and serotoninergic receptors of type 5-HT1A and 5-HT2 and to pharmaceutical composition showing affinity to dopaminergic receptors of type D2 and D3 and serotoninergic receptors of type 5-HT1A and 5-HT2 containing compound of the formula (I) and excipient. Invention provides synthesis of novel derivatives of 8-azabicyclo[3.2.1]octane- -3-methanamine. EFFECT: valuable medicinal and pharmacological properties of compounds. 6 cl, 3 tbl
机译:领域:有机化学,医学,药理学。物质:本发明涉及作为通式(I)的纯几何异构体的8-氮杂双环[3.2.1]辛烷-3-甲胺的新型衍生物。其中U表示公式(A)<图像文件=“ 00000005.GIF” he =“ 18” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 39“ />或(B)<图像文件=” 00000006.GIF“ he =” 18“ imgContent =” undefined“ imgFormat =” GIF“ wi =” 45“ />其中V代表氢或卤素原子,(C < Sub> 1 -C 3 )-烷基或两个(C 1 -C 3 )-烷氧基中的一个; W和X分别代表两个氧原子:氧原子和CH 2 基团或CH 2 基和氧原子,氧原子和CO基团。 n = 0或1;当U表示式(A)时,R代表丙基,当氢表示式(B)时,R代表丙基或氢原子或(C 1 -C 3 )-烷基。 Y表示一个或多个原子或基团,包括氢,卤素原子等; Z代表氢,氧原子。本发明还涉及对式D 2 和D 3 的多巴胺能受体和5-HT 的5-羟色胺能受体具有亲和性的含式(I)化合物的药物。 1A 和5-HT 2 以及对D 2 和D 3 型多巴胺能受体和5-羟色胺能受体具有亲和力的药物组合物含有式(I)化合物和赋形剂的5-HT 1A 和5-HT 2 类型。本发明提供了8-氮杂双环[3.2.1]辛烷-3-甲胺的新型衍生物的合成。功效:该化合物的重要药用和药理特性。 6厘升,3汤匙

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号